Merck KGaA to Acquire Bio-Techne for $11.3 Billion

German pharmaceutical and chemical company Merck KGaA has announced its acquisition of Bio-Techne for $11.3 billion, aiming to expand its presence in the life sciences sector. The deal is intended to strengthen Merck's position in the biotechnology and laboratory supplies industry. The acquisition will be executed through a cash payment of $100 per share, representing a premium of approximately 20% over Bio-Techne's latest closing price. With this move, Merck plans to enhance its capabilities in high-growth areas such as cell and gene therapy. Bio-Techne, known for its protein and antibody-based research tools, generated approximately $1.1 billion in revenue in 2023. This acquisition is seen as part of Merck's growth strategy in its life sciences segment. The transaction is expected to close in the first half of 2025, subject to regulatory approvals. Merck anticipates that the merger will generate over $200 million in annual synergies. This is not investment advice.

📊 BIO — Piyasa Yorumu

▲ up · 75%

The news announces that Bio-Techne will be acquired by Merck KGaA for $11.3 billion. Such acquisition news typically leads to a significant rise in the stock price. Technical indicators also support this uptrend: RSI at 68 indicates strong buying territory, MACD is above the signal line, and the price is above both the 20-day and 50-day moving averages. The 4.3% increase in the last 24 hours suggests continued momentum. The upward movement is expected to persist in the short term.

RSI 14

68.1

MACD

0.34

24h Δ

4.29%

📊 TECH — Piyasa Yorumu

▲ up · 70%

The news announces that Bio-Techne will be acquired by Merck KGaA for $11.3 billion. Such acquisition news typically has a positive impact on the target company's stock price. Technical indicators also point to an overbought zone (RSI 83.9) and a strong uptrend. However, given that the price has already risen by 22% and the RSI is overbought, some profit-taking or consolidation may occur in the short term. Nevertheless, as the acquisition news will provide strong support for the stock, the upward trend is expected to continue.

RSI 14

83.9

MACD

1.72

24h Δ

21.96%

Canlı Grafikler